AWM
COCP icon

Activest Wealth Management’s Cocrystal Pharma COCP Stock Holding History

Activest Wealth Management’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$2 – 1160
2025
Q2 		$1 Hold
1
– – ﹤0.01% 1047
2025
Q1 		$1 Hold
1
– – ﹤0.01% 1047
2024
Q4 		$2 Hold
1
– – ﹤0.01% 893
2024
Q3 		$2 Hold
1
– – ﹤0.01% 569
2024
Q2 		$2 Buy
+1
New +$2 ﹤0.01% 522

Other funds holding COCP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Activest Wealth Management's COCP Position: Q3 2025 in Review

Activest Wealth Management sold out of Cocrystal Pharma (COCP) in Q3 2025, closing a stake of 1 share — an estimated $2 sold.

Activest Wealth Management first reported a position in COCP in Q2 2024 and held it in 5 quarters. The position peaked at $2 in Q4 2024. 22 funds tracked by Wall St. Rank hold COCP as of Q3 2025.

  • Activest Wealth Management reported no remaining Cocrystal Pharma position as of Q3 2025 after selling out during the quarter.
  • Activest Wealth Management sold 1 Cocrystal Pharma share in Q3 2025, an estimated $2.
  • Activest Wealth Management first reported a position in Cocrystal Pharma in Q2 2024 and held it in 5 quarters.
  • Activest Wealth Management's Cocrystal Pharma position peaked at $2 in Q4 2024.
  • 22 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2025.

Based on Activest Wealth Management's 13F filing for Q3 2025, filed 3 Nov 2025.